The unique characteristics of COVID-19 coagulopathy.

Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. · 2020

Read The unique characteristics of COVID-19 coagulopathy. by Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7301352.txt.

Description

Iba and co-authors define what makes COVID-19's clotting disorder distinct from other coagulopathies doctors know. Their review appeared in Critical Care. Clots and abnormal clotting tests are frequent in COVID-19, but the pattern does not match bacterial sepsis or classic disseminated intravascular coagulation.

In COVID-19-associated coagulopathy, D-dimer and fibrinogen rise sharply while clotting time and platelet counts stay nearly normal at first. Vein and artery clots are more frequent than in sepsis-driven disease. Features overlap partly with hemophagocytic syndrome, antiphospholipid syndrome, and thrombotic microangiopathy, but not fully with any of them. Sorting these similarities and differences, the authors argue, is what allows correct diagnosis and anticlotting treatment.

Catalog record

CREATORIba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7301352

Browse the full library · About the Tower of Babel